Literature DB >> 14763912

Direct causes of death in Japanese patients with hypopituitarism as analyzed from a nation-wide autopsy database.

Hidesuke Kaji1, Kazuo Chihara.   

Abstract

OBJECTIVES: The direct causes of death in Japanese patients with hypopituitarism remain unclear. In this study, the direct causes of death were investigated and compared between Japanese patients with hypopituitarism from a nation-wide autopsy database and an age- and gender-matched control population from national reports.
SUBJECTS: Three hundred and ninety-one subjects with hypopituitarism who had died were selected from a nation-wide autopsy database (1984-1993). The ratios of each cause of death among the age- and gender-matched control population were derived from national reports.
RESULTS: In subjects with hypopituitarism, an increased relative frequency of death from cerebrovascular diseases (male; 2.02 (95% confidence interval (CI) 1.45-2.82), female; 1.73 (95% CI 1.18-2.52)) was found. In particular, the relative frequency of death from cerebral hemorrhage was 4.60 (95% CI 2.95-7.17) in male and 4.80 (95% CI 2.90-7.94) in female subjects with hypopituitarism. Unexpectedly, a decreased relative frequency of death from all heart diseases (male; 0.439 (95% CI 0.277-0.696), female; 0.267 (95% CI 0.149-0.478)) was found in subjects with hypopituitarism, although there was no difference between subjects with hypopituitarism and controls in the frequency of death from ischemic heart disease.
CONCLUSIONS: These results provide useful information for the long-term care of Japanese patients with hypopituitarism.

Entities:  

Mesh:

Year:  2004        PMID: 14763912     DOI: 10.1530/eje.0.1500149

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 2.  Mortality in adults with hypopituitarism: a systematic review and meta-analysis.

Authors:  Sina Jasim; Fares Alahdab; Ahmed T Ahmed; Shrikant Tamhane; Larry J Prokop; Todd B Nippoldt; M Hassan Murad
Journal:  Endocrine       Date:  2016-11-05       Impact factor: 3.633

Review 3.  Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.

Authors:  Xin He; Ariel L Barkan
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

4.  Cerebral vasoreactivity, a surrogate marker of cerebrovascular disease, is not impaired in subjects with lifetime, untreated, congenital isolated GH deficiency.

Authors:  Cindi G Marinho; Hyder A Melo; Roberto Salvatori; Marco A P Nunes; Carla R P Oliveira; Viviane C Campos; Cynthia S Barros-Oliveira; Alécia A Oliveira-Santos; Nelmo V Menezes; Hertz T Santos-Júnior; Elenilde G Santos; Manuela A Melo; Joselina L M Oliveira; Enaldo V Melo; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2020-07-12       Impact factor: 3.633

5.  Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency.

Authors:  Hitoshi Kohno; Toshiaki Tanaka; Kenji Fujieda; Kazuo Chihara; Yoshiki Seino; Minoru Irie; Kazue Takano
Journal:  Clin Pediatr Endocrinol       Date:  2012-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.